Healthpoint Takes Over Marketing and Selling of Collagenase Ointment
Healthpoint (Fort Worth, Tex) announces that the company will begin marketing and selling the Collagenase Santyl® Ointment product line.
The marketing and selling of the ointment builds on the March 2006 announcement that the company purchased the topical collagenase business from BioSpecifics Technologies Corp. (Lynbrook, NY). The companies plan to invest $1.5 million in upgrading the newly acquired manufacturing facilities, which currently produce Collagenase ABC, the essential ingredient in the prescription drug Collagenase Santyl.
The sterile enzymatic ointment is used to debride pressure ulcers, chronic dermal ulcers, and severely burned areas by digesting collagen, a major component of devitalized tissue. The enzyme collagenase is derived from the fermentation of the bacterium Clostridium histolyticum.
Work is underway to ensure no disruption in supply, quality, and customer service occurs as Healthpoint takes on manufacturing, distributing, and marketing the ointment.
Visit http://www.healthpoint.com for more information.
Onset Therapeutics to Develop and Commercialize Wound Care, Dermatology Products Onset Therapeutics (Woonsocket, RI), a specialty pharmaceutical company that focuses on the development and commercialization of innovative, patent-protected topical products for skin and wound-related disorders, launched the first in a series of prescription wound care products at the Symposium on Advanced Wound Care (SAWC) held in San Antonio, Tex, April 30–May 3, 2006.
Development and commercialization of novel therapies with clinical enhancements over existing products in the market is the core of the company’s strategy. With significant development capabilities that include formulation development through GMP manufacturing, the company looks to market numerous topical products within the wound care and dermatology markets in 2006. In addition, the company has a full pipeline of products that it intends to launch over the next 3 years that incorporate the company’s novel Foam Vehicle Technology.
Visit http://www.onsettx.com for more information.
L&M Healthcare Communications Announces Official Launch L&M Healthcare Communications (Scotch Plains, NJ) announces the opening of its new medical education agency led by Lenny LaManna, DPM, and Adam Margolis. Dr. LaManna and Mr. Margolis have nearly 30 years of combined experience in pharmaceutical marketing and medical education. The team’s unique expertise will serve to ensure that L&M clients receive the best custom medical education programs and campaign resources including thought-leader/advocacy development, speaker training, custom speakers’ bureaus, consulting services, and core educational launch materials and publications.
Robert Kirsner, MD, PhD, Vice Chair and Professor, Department of Dermatology, University of Miami Miller School of Medicine, said, “Lenny and Adam bring to the table the essential components of successful medical education—highly strategic and medically accurate content with excellent program execution and customer service. It has been my pleasure to collaborate with them.”
The L&M staff is highly experienced in many therapeutic areas including central nervous system diseases, dermatologic conditions, wound healing, autoimmune diseases, gastroenterology, and cardiology. This knowledge, plus the company’s commitment to client service, is what differentiates L&M from other agencies.
Visit http://www.LMHCare.com for more information.
|
